IL-17 and IFN-γ mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat

被引:118
作者
Li, HL [1 ]
Kostulas, N [1 ]
Huang, YM [1 ]
Xiao, BG [1 ]
van der Meide, P [1 ]
Kostulas, V [1 ]
Giedraitas, V [1 ]
Link, H [1 ]
机构
[1] Karolinska Inst, Huddinge Univ Hosp, Div Neurol, Neuroangiol Res Ctr, Stockholm, Sweden
关键词
IL-17; IFN-gamma; inflammation; cerebral ischemia;
D O I
10.1016/S0165-5728(01)00264-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Brain ischemia is characterized by local inflammation reflected by accumulation of inflammatory cells and a multitude of mediators. Among them, cytokines and chemokines may influence the inflammatory cascade that follows cerebral ischemia. Here we report on brain hemispheric and systemic increase of pro-inflammatory IL-17 and IFN-gamma, the anti-inflammatory cytokines IL-4 and IL-10, and the chemokines IP-10, IL-8 and MIP-2, 1 h to 6 days after permanent middle cerebral artery occlusion (pMCAO). IL-17 and IFN-gamma mRNA levels were elevated in the ischemic hemispheres of pMCAO-operated rats compared with corresponding hemispheres of sham-operated rats. Levels were slightly elevated at 1 h, and peaked at 6 days after pMCAO. IL-8 and MIP-2 levels in the ischemic hemispheres peaked at 24 h, whereas IP-10 showed a biphasic profile with two peaks at 6 h and 6 days after pMCAO. IL-4 peaked in the ischemic hemispheres at 6 h, when IL-10 levels were lower than in sham-operated rats, and IL-10 levels peaked at 2 days after pMCAO. Systemically, the numbers of IL-17 and IFN-gamma mRNA expressing blood mononuclear cells were elevated already at 1 h after pMCAO, preceding the changes in the ischemic hemispheres. Altered levels of IL-17 and IFN-gamma after pMCAO may affect outcome of brain ischemia. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 31 条
[1]  
Baggiolini M, 1992, Cytokines, V4, P1
[2]   Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA [J].
Bai, XF ;
Shi, FD ;
Xiao, BG ;
Li, HL ;
vanderMeide, PH ;
Link, H .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) :65-75
[3]   DEVELOPMENT OF TISSUE-DAMAGE, INFLAMMATION AND RESOLUTION FOLLOWING STROKE - AN IMMUNOHISTOCHEMICAL AND QUANTITATIVE PLANIMETRIC STUDY [J].
CLARK, RK ;
LEE, EV ;
FISH, CJ ;
WHITE, RF ;
PRICE, WJ ;
JONAK, ZL ;
FEUERSTEIN, GZ ;
BARONE, FC .
BRAIN RESEARCH BULLETIN, 1993, 31 (05) :565-572
[4]  
COLDITZ I, 1989, AM J PATHOL, V134, P755
[5]   Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion - Role of neutrophil adhesion in the pathogenesis of stroke [J].
Connolly, ES ;
Winfree, CJ ;
Springer, TA ;
Naka, Y ;
Liao, H ;
Yan, SD ;
Stern, DM ;
Solomon, RA ;
GutierrezRamos, JC ;
Pinsky, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :209-216
[6]   REVERSE ELISPOT ASSAY FOR CLONAL ANALYSIS OF CYTOKINE PRODUCTION .1. ENUMERATION OF GAMMA-INTERFERON-SECRETING CELLS [J].
CZERKINSKY, C ;
ANDERSSON, G ;
EKRE, HP ;
NILSSON, LA ;
KLARESKOG, L ;
OUCHTERLONY, O .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 110 (01) :29-36
[7]   SENSITIVE MESSENGER-RNA DETECTION USING UNFIXED TISSUE - COMBINED RADIOACTIVE AND NONRADIOACTIVE INSITU HYBRIDIZATION HISTOCHEMISTRY [J].
DAGERLIND, A ;
FRIBERG, K ;
BEAN, AJ ;
HOKFELT, T .
HISTOCHEMISTRY, 1992, 98 (01) :39-49
[8]   Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1α attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis [J].
Diab, A ;
Abdalla, H ;
Li, HL ;
Shi, FD ;
Zhu, J ;
Höjberg, B ;
Lindquist, L ;
Wretlind, B ;
Bakhiet, M ;
Link, H .
INFECTION AND IMMUNITY, 1999, 67 (05) :2590-2601
[9]   The role of cytokines in the neuropathology of stroke and neurotrauma [J].
Feuerstein, GZ ;
Wang, XK ;
Barone, FC .
NEUROIMMUNOMODULATION, 1998, 5 (3-4) :143-159
[10]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095